Literature DB >> 1456747

Alpha-tocopherol levels in brain are not altered in Parkinson's disease.

D T Dexter1, R J Ward, F R Wells, S E Daniel, A J Lees, T J Peters, P Jenner, C D Marsden.   

Abstract

alpha-Tocopherol (vitamin E) levels in normal brain were lower in the cerebellum than in the cerebral cortex or basal ganglia. There was no difference in alpha-tocopherol levels in the cerebellum, basal ganglia, or cerebral cortex between control subjects and patients with Parkinson's disease.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1456747     DOI： 10.1002/ana.410320420

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


  14 in total

1.  Oxidatively generated DNA damage after Cu(II) catalysis of dopamine and related catecholamine neurotransmitters and neurotoxins: Role of reactive oxygen species.

Authors:  Wendy A Spencer; Jeyaprakash Jeyabalan; Sunita Kichambre; Ramesh C Gupta
Journal:  Free Radic Biol Med       Date:  2010-11-12       Impact factor: 7.376

Review 2.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease.

Authors:  J A Molina; F de Bustos; F J Jiménez-Jiménez; J Benito-León; M Ortí-Pareja; T Gasalla; A Tallón-Barranco; J A Navarro; J Arenas; R Enríquez-de-Salamanca
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Single-cell lipidomics: characterizing and imaging lipids on the surface of individual Aplysia californica neurons with cluster secondary ion mass spectrometry.

Authors:  Melissa K Passarelli; Andrew G Ewing; Nicholas Winograd
Journal:  Anal Chem       Date:  2013-02-04       Impact factor: 6.986

Review 5.  Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.

Authors:  Chun Zhou; Yong Huang; Serge Przedborski
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 6.  Antioxidants in central nervous system diseases: preclinical promise and translational challenges.

Authors:  Chandrashekhar D Kamat; Sunyana Gadal; Molina Mhatre; Kelly S Williamson; Quentin N Pye; Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

7.  The promise of neuroprotective agents in Parkinson's disease.

Authors:  Stacey E Seidl; Judith A Potashkin
Journal:  Front Neurol       Date:  2011-11-21       Impact factor: 4.003

8.  Iron and inflammation: in vivo and post-mortem studies in Parkinson's disease.

Authors:  Antonio Martin-Bastida; Bension Shlomo Tilley; Sukhi Bansal; Steve M Gentleman; David T Dexter; Roberta J Ward
Journal:  J Neural Transm (Vienna)       Date:  2020-10-20       Impact factor: 3.575

Review 9.  Glutathione in the Brain.

Authors:  Koji Aoyama
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

Review 10.  Inhibition of GTRAP3-18 may increase neuroprotective glutathione (GSH) synthesis.

Authors:  Koji Aoyama; Toshio Nakaki
Journal:  Int J Mol Sci       Date:  2012-09-20       Impact factor: 6.208
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.